But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Discover top energy & healthcare stocks with strong momentum and Buy ratings, plus ETFs for diversified sector investment.

From data-driven validation to hands-on customer engagement, there are proven strategies that can help you assess and, if ...

For income investors, closed-end funds remain an attractive investment class. Check out this month's five CEFs with solid ...

The EMA's human medicines advisory committee has recommended that BioMarin Pharmaceutical's haemophilia A gene therapy Roctavian be approved in the EU, removing one of the last barriers to launch.

BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...